EUVIMEDEUVIMED entdecken
Crossref

Co‐Delivery of Multiple RNAs via Lipid Nanoparticles Enables Precise Gene Editing of CAR‐T Cells

Mengge Wang, Qibin Liao, Shimeng Bai, Xiaoyi Liu, Yuanzheng Peng, Pengpeng Liu, Hongzhou Lu, Jian-Kang Zhu, Chen Zeng iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202501475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Mengge Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Advanced Biotechnology, Institute of Homeostatic Medicine, and School of Medicine, Southern University of Science and Technology, Shenzh…. Hauptthemen laut MEDLINE: Gene Editing, Nanoparticles, Lipids, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Shenzhen Science and Technology Program, Guangdong S&T Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past decade, CAR‐T cell therapy has achieved remarkable success in treating hematological malignancies. However, traditional CAR‐T cell engineering employs viral vectors, which has several limitations. Additionally, the immunosuppressive tumor microenvironment, particularly mediated by the PD‐1/PD‐L1 pathway, significantly restricts CAR‐T cell efficacy. CRISPR/Cas9‐mediated PD‐1 knockout can enhance CAR‐T cell anti‐tumor activity, but traditional electroporation (EP) method often damages T cells. Herein, a novel lipid nanoparticles (LNPs)‐mediated delivery technology are introduced to engineer CAR‐T cells. The LNPs platform enables the simultaneous expression of CAR cassette and CRISPR/Cas9 gene editor in T cells via co‐delivery of multiplex RNAs (CD19 CAR mRNA+Cas9 mRNA+sgRNA targeting PD‐1). Importantly, LNPs exhibit higher transfection efficiency and superior cell viability compared to traditional electroporation method. The engineered CAR‐T cells with PD‐1 knockout, which express anti‐CD19 CAR, can specifically kill CD19+ Nalm‐6 tumor cells in vitro and display enhanced anti‐tumor activity in vivo. Furthermore, LNPs‐mediated co‐delivery of Cas9 mRNA and sgRNAs targeting PD‐1, TRAC, and B2M enables triple‐knockout of T cells with high editing efficiencies (76% for PD‐1, 86% for TRAC, and 80% for B2M), highlighting the ability for multiplex gene editing. This LNP‐mediated delivery strategy has great potentials for the development of safer and more efficacious CAR‐T cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingNanoparticlesLipidsReceptors, Chimeric AntigenT-LymphocytesImmunotherapy, AdoptiveRNAHumansAnimalsMiceCRISPR-Cas SystemsCell Line, TumorProgrammed Cell Death 1 ReceptorGene Transfer TechniquesLiposomes

Stichwörter der Autor:innen

CAR‐T cellsLNPsRNA deliverygene editing

Substanzen

Lipid NanoparticlesLipidsReceptors, Chimeric AntigenProgrammed Cell Death 1 ReceptorRNALiposomes

Autor:innen und Institutionen

  • Institute of Advanced Biotechnology, Institute of Homeostatic Medicine, and School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, China.
  • Shenzhen Third People's Hospital, The Second Affiliated Hospital, Southern University of Science and Technology, Shenzhen, 518112, China.
  • State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, 511436, China.
  • Kidney Transplant Department (Liver Transplant Department), Transplant Center, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, Southern Univers…
  • National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, The Second Affiliated Hospital, Southern University of Science and Technology, Shenzhen, 518112, China.

ORCID-Profile: Chen Zeng

Förderung

  • Shenzhen Science and Technology Program
  • Guangdong S&T Program
  • National Natural Science Foundation of China
  • "Open Competition to Select the Best Candidates" Technology Breakthrough Project for Cell Therapy of NCTIB
  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Wang, M., Liao, Q., Bai, S., Liu, X., Peng, Y., Liu, P., Lu, H., Zhu, J. K., & Zeng, C. (2026). Co‐Delivery of Multiple RNAs via Lipid Nanoparticles Enables Precise Gene Editing of CAR‐T Cells. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202501475

Vancouver

Wang M, Liao Q, Bai S, Liu X, Peng Y, Liu P, et al. Co‐Delivery of Multiple RNAs via Lipid Nanoparticles Enables Precise Gene Editing of CAR‐T Cells. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202501475

BibTeX
@article{Wang2026,
  author = {Wang, Mengge and Liao, Qibin and Bai, Shimeng and Liu, Xiaoyi and Peng, Yuanzheng and Liu, Pengpeng and Lu, Hongzhou and Zhu, Jian-Kang and Zeng, Chen},
  title = {Co‐Delivery of Multiple RNAs via Lipid Nanoparticles Enables Precise Gene Editing of CAR‐T Cells},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202501475}
}
Kostenlos starten →